Log In
Print this Print this

Avandaryl, rosiglitazone/glimepiride

Also known as: Avaglim

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionFixed-dose combination of rosiglitazone maleate and glimepiride
Molecular Target Peroxisome proliferation activated receptor (PPAR) gamma
Mechanism of ActionPeroxisome proliferation activated receptor (PPAR) alpha agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationDiabetes
Indication DetailsAdjunct to improve glycemic control in Type II diabetes patients
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today